Charles Schwab Q4 Profit Rises, But Results Miss Estimates - Quick Facts

Charles Schwab Corp. (SCHW) reported Tuesday that net income available to common shareholders for the fourth quarter grew to $1.58 billion or $0.76 per share from $1.14 billion or $0.57 per share in the year-ago quarter.

Excluding items, adjusted earnings for the quarter were $0.86 per share, compared to $0.74 per share in the prior-year quarter.

Net revenues for the quarter grew 13 percent to $4.71 billion from $4.18 billion in the same quarter last year.

On average, analysts polled by Thomson Reuters expected the company to report earnings of $0.88 per share on revenues of $4.79 billion for the quarter. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Teva Pharmaceuticals USA, Inc. has recalled one lot of platelet-reducing drug Anagrelide in the form of capsules due to dissolution test failure detected during routine stability testing, the U.S. Food and Drug Administration, or FDA, said in a statement. The U.S. Food and Drug Administration said it has taken steps to make available millions of cans of additional infant and specialty formula to U.S. consumers in the coming months. Under the agency's recent increased flexibilities, British nutrition products maker Kendal Nutricare will send about 2 million cans of infant formula under the Kendamil brand initially to U.S. beginning in June. Video streaming giant Netflix Inc. announced the availability of a variety of mobile games. Players can download the games directly from the Netflix mobile app. The new games include Dragon Up (East Side Games), Moonlighter (11 Bit Studios), Townsmen - A Kingdom Rebuilt (HandyGames), and Exploding Kittens - The Game (Exploding Kittens Digital).
Follow RTT